Skip to main content

and
  1. Article

    Open Access

    Kremen2 drives the progression of non-small cell lung cancer by preventing SOCS3-mediated degradation of EGFR

    The transmembrane receptor Kremen2 has been reported to participate in the tumorigenesis and metastasis of gastric cancer. However, the role of Kremen2 in non-small cell lung cancer (NSCLC) and the underlying ...

    Yuxiao Sun, Yu Gao, Mingxin Dong, Jiuzhen Li in Journal of Experimental & Clinical Cancer … (2023)